Bill Number: SB1151
Bill Sponsor(s): Senator King
Subject: Budget and Taxation
Altering the definition of “qualified Maryland biotechnology company” to repeal certain limitations on the period of time for which a company may have been in active business for purposes of eligibility for the biotechnology tax credit; declaring the intent of the General Assembly that the credit will encourage private sector investment in Maryland biotechnology companies; altering a certain limitation on the aggregate credits that the Secretary of Commerce may certify for certain investments; applying the Act; etc.
Members read more about our positioning within our Members Only section.